6669 — Acotec Scientific Holdings Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Annual cashflow statement for Acotec Scientific Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	26.7	-31.4	-67.2	70.3	14.5
Depreciation
Amortisation
Non-Cash Items	1.73	56.7	67	-5.46	-5.47
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-12.5	-39.4	-19.9	-153	-68.1
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	19.9	-8.77	-10.5	-68.8	-12.9
Capital Expenditures	-2.7	-18.6	-21.2	-46.7	-79.7
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	0.38	0.892	0.762	-2.47	-240
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-2.32	-17.7	-20.5	-49.2	-319
Financing Cash Flow Items	-1.35	-4.03	-67.2	-1.76	-9.96
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-3.19	143	1,024	-32.9	-23.2
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	14.3	116	990	-151	-349